Uncovering Potential Life Cycle Opportunities in Oncology Using a Patient-Centric Outcomes-based Approach
This article was published in the Pharmaceutical Executive which can be accessed via https://www.pharmexec.com/view/uncover-potential-life-cycle-opportunities-in-oncology-using-patient-centric-outcomes
Overview
Life cycle management is often viewed as a discrete event in product development and commercialization. However, it must be considered a continuous process that allows biopharma companies to increase a product's value over its lifetime. This white paper outlines the importance of the patient-centric approach in uncovering life cycle opportunities in the Oncology therapeutic area as the field is rapidly evolving. This patient-centric approach broadly focuses on all aspects of the patient journey (prevention, diagnosis, treatment, and care monitoring) and outcomes that create value for stakeholders. This paper is organized into three sections to answer the following questions.:
Part A. How is the oncology therapeutic area transforming?
Part B. How does a patience-centric approach help with life cycle planning?
B1. Importance of diagnostic approaches in personalized treatments
B2. Treatment optimization to generate best clinical outcomes
B3. Patient care management to improve overall health outcomes
Part C. How can a patient-centric framework uncover life cycle opportunities?
Authors
Subbarao Jayanthi, Managing Partner of RxC International
Nick DeSanctis, Executive Partner at RxC International
About RXC International
RxC International is a premier biopharma strategy consulting firm helping clients with growth strategies. The firm has deep expertise in new product planning and commercialization strategy. Our clients include leading pharmaceutical and biotechnology companies around the world. The firm has offices in New Jersey, Massachusetts, and California. Additional information about RxC International is available at www.RxCInternational.com.
If you have any questions or need additional information, please contact us at info@RxCinternational.com
Featured in the Pharmaceutical Executive in March 2021